$16.23
-1.76-9.81%
Last update: Nov 6, 12:52 PM
Tandem Diabetes Care Inc
TNDMNASDAQ
The average analyst price target for Tandem Diabetes Care is $27.90, 72.0% above the current price. Of 20 analysts, 11 rate it Buy and 9 Hold. Targets range from $12 to $60. The latest change came on Nov 6, 2026, when Barclays raised its price target on Tandem Diabetes Care from $18 to $20 and kept an Equal-Weight rating.
Price Target Range — 11 Quarters
Analyst Consensus — 20 Analysts
Rating Trend — Last 9 Months
